CIS Pharma AG

CIS Pharma is an innovator in the life science industry in the field of Oncology and Ophthalmolog. We were awarded with the European Frost & Sullivan Technology Innovation Award for our unique smart polymer technologyœ, says Christoph Schäfer, CEO of CIS Pharma. Our proprietary polymers are based on amino-acids exhibiting superior biocompatibility, resolving issues with conventional medical-grade polymers for bio-medical use. The polymers can be loaded with drugs for target-specific release, improving the quality of patient care and addressing unmet medical needs. With its intelligent functionally, the poylmers are finding strong prospects in various bio-medical applications. The most noticeable factor is the control over chemical and physical properties, explains Mukherjee of Frost and Sullivan. With such intelligent functionality, the polymer platform opens a wide range of applications for drug delivery, bio-medical implants and replacements.